172 related articles for article (PubMed ID: 15255939)
1. Neuronal A1 receptors mediate increase in extracellular kynurenic acid after local intrastriatal adenosine infusion.
Wu HQ; Fuxe K; Schwarcz R
J Neurochem; 2004 Aug; 90(3):621-8. PubMed ID: 15255939
[TBL] [Abstract][Full Text] [Related]
2. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
[TBL] [Abstract][Full Text] [Related]
3. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
[TBL] [Abstract][Full Text] [Related]
4. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Tebano MT; Pintor A; Frank C; Domenici MR; Martire A; Pepponi R; Potenza RL; Grieco R; Popoli P
J Neurosci Res; 2004 Jul; 77(1):100-7. PubMed ID: 15197743
[TBL] [Abstract][Full Text] [Related]
6. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
[TBL] [Abstract][Full Text] [Related]
7. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
8. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant effect of A1 but not A2A adenosine receptors of piriform cortex in amygdala-kindled rats.
Rezvani ME; Mirnajafi-Zadeh J; Fathollahi Y; Palizvan MR
Can J Physiol Pharmacol; 2007 Jun; 85(6):606-12. PubMed ID: 17823622
[TBL] [Abstract][Full Text] [Related]
10. Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum.
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2002 Mar; 109(3):239-49. PubMed ID: 11956948
[TBL] [Abstract][Full Text] [Related]
11. Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum.
Rassoulpour A; Wu HQ; Ferre S; Schwarcz R
J Neurochem; 2005 May; 93(3):762-5. PubMed ID: 15836634
[TBL] [Abstract][Full Text] [Related]
12. Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.
Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
Synapse; 2006 Apr; 59(5):290-8. PubMed ID: 16416446
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.
Amori L; Wu HQ; Marinozzi M; Pellicciari R; Guidetti P; Schwarcz R
Neuroscience; 2009 Mar; 159(1):196-203. PubMed ID: 19138730
[TBL] [Abstract][Full Text] [Related]
14. Sustained elevation of extracellular adenosine and activation of A1 receptors underlie the post-ischaemic inhibition of neuronal function in rat hippocampus in vitro.
Pearson T; Damian K; Lynas RE; Frenguelli BG
J Neurochem; 2006 Jun; 97(5):1357-68. PubMed ID: 16696848
[TBL] [Abstract][Full Text] [Related]
15. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
16. High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum.
Okuno A; Fukuwatari T; Shibata K
J Neurochem; 2011 Sep; 118(5):796-805. PubMed ID: 21711351
[TBL] [Abstract][Full Text] [Related]
17. Changes in neuromodulatory effect of adenosine A1 receptors on piriform cortex field potentials in amygdala kindled rats.
Rezvani ME; Mirnajafi-Zadeh J; Fathollahi Y; Palizvan MR
Eur J Pharmacol; 2007 Jun; 565(1-3):60-7. PubMed ID: 17359967
[TBL] [Abstract][Full Text] [Related]
18. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
Wu HQ; Rassoulpour A; Goodman JH; Scharfman HE; Bertram EH; Schwarcz R
Epilepsia; 2005 Jul; 46(7):1010-6. PubMed ID: 16026552
[TBL] [Abstract][Full Text] [Related]
19. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
Beggiato S; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K; Schwarcz R; Ferraro L
Eur J Neurosci; 2013 May; 37(9):1470-7. PubMed ID: 23442092
[TBL] [Abstract][Full Text] [Related]
20. Adenosine inhibits basal forebrain cholinergic and noncholinergic neurons in vitro.
Arrigoni E; Chamberlin NL; Saper CB; McCarley RW
Neuroscience; 2006 Jun; 140(2):403-13. PubMed ID: 16542780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
